- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02538250
Acceptability Study on Oral Nutrition Supplement (ONS)
October 12, 2016 updated by: B. Braun Medical UK Ltd.
Acceptability Study on Nutricomp Drink Plus in Adult Patients
Required for Advisory Committee for Borderline Substances (ACBS) approval.
Aim of this study is to access the palatability, compliance and GI-tolerance of Nutricomp® Drink Plus to show that it is acceptable for patients in the United Kingdom.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sheffield, United Kingdom, S10 2JF
- Sheffield Teaching Hospitals NHS Foundation Trust, The Royal Hallamshire Hospital, Regional Gastrointestinal and Liver Unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion:
- Male and female patients
- ≥ 18 years of age
- Patients of the intended target group (e.g. MUST score ≥ 1) with an anticipated period of nutritional support ≥ 7 days
- Patient is able and willing to provide written informed consent
Exclusion:
- Hypersensitivity to milk, whey, soy, fish or any of the active substances or excipients
- Patients with available or potential impairment of sense of taste or smell due to disease (e.g. patients with cold, cancer patients) or medication (e.g. D-Penicillamine)
- Patients who express general dislike to two or more of the four flavours
- Severely impaired gastrointestinal function or complete failure
- Severe metabolic or circulatory disorders
- Acute disease
- Unstable vital functions
- Necessity of total parenteral nutrition or more than 50% Parenteral Nutrition in combined therapy
- Simultaneous participation in another interventional study
- Patients who are unwilling or mentally and/or physically unable to adhere to study procedures
- Pregnancy
- Emergencies
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1 Nutricomp Drink Plus
Nutricomp Drink Plus
|
Oral nutritional supplementation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Occurrence of gastrointestinal tolerance parameters (Diarrhoea, Constipation, Bloating, Distension, Nausea, Vomiting, Burping, Regurgitation, Flatulence, Abdominal discomfort, Abdominal pain, Other (further gastrointestinal adverse events)
Time Frame: 7 days
|
Parameters asked as required for acceptability studies by Advisory Committee for Borderline Substances- documented in a patient diary
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Occurrence of further adverse effects
Time Frame: 7 days
|
7 days
|
|
Evaluation of palatability by questionnaire
Time Frame: 1 day
|
Five point hedonic scale
|
1 day
|
Evaluation of compliance.
Time Frame: 7 days
|
Comparison of prescription and actual intake
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David Sanders, Prof., The Royal Hallamshire Hospital,Regional Gastrointestinal and Liver Unit, Sheffield, UK
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2015
Primary Completion (Actual)
October 1, 2015
Study Completion (Actual)
October 1, 2015
Study Registration Dates
First Submitted
June 24, 2015
First Submitted That Met QC Criteria
September 1, 2015
First Posted (Estimate)
September 2, 2015
Study Record Updates
Last Update Posted (Estimate)
October 13, 2016
Last Update Submitted That Met QC Criteria
October 12, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- HC-G-H-1422
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Nutritional Supplementation
-
Centre Hospitalier Universitaire DijonCompletedMalnutrition | Oral Nutritional SupplementationFrance
-
B. Braun Melsungen AGCompletedAdult Patients in Need of High-energy Oral Nutritional SupplementationUnited Kingdom
-
Metabolic Technologies Inc.CompletedFocus of the Study is to Examine Plasma HMB Levels After Oral HMB SupplementationUnited States
-
Texas A&M UniversityNutrition 21, Inc.Completed
-
Rabin Medical CenterNG Solutions LtdActive, not recruitingGrowth | Nutritional SupplementationIsrael
-
Universidad Católica San Antonio de MurciaCompleted
-
University of New MexicoAbbVieNot yet recruitingGlabellar Frown Lines | Adjuvant Zinc May Increase the Efficacy of Botulinum Toxin | Zinc Supplementation for Botulinum Toxin Treatment of the Forehead | Botulinum Toxin, Cosmetic | Adjuvant Oral Zinc and Botulinum Toxin
-
California Baptist UniversityCompletedDietary SupplementationUnited States
-
Poznan University of Life SciencesNational Science Centre, PolandUnknown
-
University of AarhusCompleted
Clinical Trials on Nutricomp Drink Plus
-
B. Braun Melsungen AGCompletedAdult Patients in Need of High-energy Oral Nutritional SupplementationUnited Kingdom
-
University of NottinghamKaneka CorporationCompletedEnteral NutritionUnited Kingdom
-
Colorado State UniversityUnited States Department of Agriculture (USDA)UnknownObesity | Overweight | Menopause | AgingUnited States
-
Virginia Polytechnic Institute and State UniversityCompletedCardiovascular Risk FactorUnited States
-
TCI Co., Ltd.Active, not recruiting
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
Maastricht University Medical CenterTop Institute Food and NutritionCompletedMuscle Loss in ElderlyNetherlands
-
Mayo ClinicCompletedCardiovascular System | Hemodynamics | Energy DrinksUnited States
-
Mondelēz International, Inc.Reading Scientific Services Ltd.CompletedGlycaemic Index | Glycaemic ResponseUnited Kingdom